CCM
RPID icon

CAAS Capital Management’s Rapid Micro Biosystems RPID Stock Holding History

CAAS Capital Management’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,777
Closed -$119K – 944
2022
Q3 		$119K Hold
27,777
– – 0.01% 695
2022
Q2 		$119K Hold
27,777
– – 0.01% 734
2022
Q1 		$189K Hold
27,777
– – 0.01% 503
2021
Q4 		$296K Sell
27,777
-211,950
-88% -$3.31M 0.01% 622
2021
Q3 		$4.43M Buy
+239,727
New +$4.95M 0.09% 215

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAAS Capital Management's RPID Position: Q4 2022 in Review

CAAS Capital Management sold out of Rapid Micro Biosystems (RPID) in Q4 2022, closing a stake of 27,777 shares — an estimated $119K sold.

CAAS Capital Management first reported a position in RPID in Q3 2021 and held it in 5 quarters. The position peaked at $4.43M in Q3 2021. 42 funds tracked by Wall St. Rank hold RPID as of Q4 2022.

  • CAAS Capital Management reported no remaining Rapid Micro Biosystems position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 27,777 Rapid Micro Biosystems shares in Q4 2022, an estimated $119K.
  • CAAS Capital Management first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 5 quarters.
  • CAAS Capital Management's Rapid Micro Biosystems position peaked at $4.43M in Q3 2021.
  • 42 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.